Advertisement
Review Article| Volume 18, ISSUE 2, P251-257, April 2023

Neuroendocrine Neoplasms

Total-body PET/Computed Tomography
  • Author Footnotes
    1 The authors contributed equally to this study.
    Guobing Liu
    Footnotes
    1 The authors contributed equally to this study.
    Affiliations
    Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, China

    Institute of Nuclear Medicine, Fudan University, Shanghai, China

    Shanghai Institute of Medical Imaging, Shanghai, China

    Cancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    Search for articles by this author
  • Author Footnotes
    1 The authors contributed equally to this study.
    Chi Qi
    Footnotes
    1 The authors contributed equally to this study.
    Affiliations
    Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, China

    Institute of Nuclear Medicine, Fudan University, Shanghai, China

    Shanghai Institute of Medical Imaging, Shanghai, China

    Cancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    Search for articles by this author
  • Hongcheng Shi
    Correspondence
    Corresponding author.
    Affiliations
    Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, China

    Institute of Nuclear Medicine, Fudan University, Shanghai, China

    Shanghai Institute of Medical Imaging, Shanghai, China

    Cancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    Search for articles by this author
  • Author Footnotes
    1 The authors contributed equally to this study.
DOI:https://doi.org/10.1016/j.cpet.2022.11.010
Neuroendocrine Neoplasms
Previous ArticleGastro-Entero-Pancreatic Tumors
Next ArticleNeuroendocrine Tumor Diagnosis

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to PET Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      Reference

        • Woltering E.A.
        • Bergsland E.K.
        • Beyer D.T.
        Neuroendocrine tumors of the stomach. American joint committee on cancer 2017.
        in: Amin M.B. AJCC cancer staging manual. Eighth Edition. Springer, 2017: 351-359
        View in Article
        • Badawi R.D.
        • Shi H.
        • Hu P.
        • et al.
        First human imaging studies with the EXPLORER total-body PET scanner.
        J Nucl Med. 2019; 60: 299-303
        View in Article
        • Alberts I.
        • Hünermund J.N.
        • Prenosil G.
        • et al.
        Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT.
        Eur J Nucl Med Mol Imaging. 2021; 48: 2395-2404
        View in Article
        • Pantel A.R.
        • Viswanath V.
        • Daube-Witherspoon M.E.
        • et al.
        PennPET explorer: human imaging on a whole-body imager.
        J Nucl Med. 2020; 61: 144-151
        View in Article
        • Zhang Y.
        • Hu P.
        • He Y.
        • et al.
        Ultrafast 30-s total-body PET/CT scan: a preliminary study [published online ahead of print, 2022 May 17].
        Eur J Nucl Med Mol Imaging. 2022; https://doi.org/10.1007/s00259-022-05838-1
        View in Article
        • Boellaard R.
        • Delgado-Bolton R.
        • Oyen W.J.
        • et al.
        FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.
        Eur J Nucl Med Mol Imaging. 2015; 42: 328-354
        View in Article
        • Sui X.
        • Liu G.
        • Hu P.
        • et al.
        Total-body PET/computed tomography highlights in clinical practice: experiences from zhongshan hospital, Fudan University.
        PET Clin. 2021; 16: 9-14
        View in Article
        • Zhang Y.Q.
        • Hu P.C.
        • Wu R.Z.
        • et al.
        The image quality, lesion detectability, and acquisition time of 18F-FDG total-body PET/CT in oncological patients.
        Eur J Nucl Med Mol Imaging. 2020; 47: 2507-2515
        View in Article
        • Hu P.
        • Zhang Y.
        • Yu H.
        • et al.
        Total-body 18F-FDG PET/CT scan in oncology patients: how fast could it be?.
        Eur J Nucl Med Mol Imaging. 2021; 48: 2384-2394
        View in Article
        • Hu Y.
        • Liu G.
        • Yu H.
        • et al.
        Feasibility of ultra-low 18F-FDG activity acquisitions using total-body PET/CT [published online ahead of print, 2021 Sep 30].
        J Nucl Med. 2021; 121 (jnumed): 262038
        View in Article
        • Tan H.
        • Cai D.
        • Sui X.
        • et al.
        Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience.
        Eur J Nucl Med Mol Imaging. 2022; 49: 1002-1011
        View in Article
        • Tan H.
        • Sui X.
        • Yin H.
        • et al.
        Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.
        Eur J Nucl Med Mol Imaging. 2021; 48: 1966-1975
        View in Article
        • Liu G.
        • Hu P.
        • Yu H.
        • et al.
        Ultra-low-activity total-body dynamic PET imaging allows equal performance to full-activity PET imaging for investigating kinetic metrics of 18F-FDG in healthy volunteers.
        Eur J Nucl Med Mol Imaging. 2021; 48: 2373-2383
        View in Article
        • Bozkurt M.F.
        • Virgolini I.
        • Balogova S.
        • et al.
        Guideline for PET/CT imaging of neuroendocrine neoplasms with (68)Ga-DOTA-conjugated somatostatin receptor targeting peptides and (18)F-DOPA [J].
        Eur J Nucl Med Mol Imaging. 2017; 44: 1588-1601
        View in Article
        • Hope T.A.
        • Bergsland E.K.
        • Bozkurt M.F.
        • et al.
        Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors.
        J Nucl Med. 2018; 59: 66-74
        View in Article
        • Lammertsma A.A.
        Forward to the past: the case for quantitative PET imaging.
        J Nucl Med. 2017; 58: 1019-1024
        View in Article
        • Pantel A.R.
        • Viswanath V.
        • Muzi M.
        • et al.
        Principles of tracer kinetic analysis in oncology, Part I: principles and overview of methodology.
        J Nucl Med. 2022; 63: 342-352
        View in Article

      Article info

      Identification

      DOI: https://doi.org/10.1016/j.cpet.2022.11.010

      Copyright

      © 2022 Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX